Loading…
Patterns of imatinib resistance mutation analysis in chronic myeloid leukemia (CML) patients on imatinib at the time of loss of response to the drug in Asian Indian subjects
Prabhash, K., Vora, T., Ghadyalpatil, N. S., Rangarajan, B., Hingmire, S. S., Menon, H., Jain, P., Kurkure, P. A., Parikh, P. M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Loading…
Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase
Iqbal, Zafar, Akram, Afia Muhammad, Akhtar, Tanveer, Aleem, Aamer, Sabar, Muhammad Farooq, Aziz, Zeba, Sajid, Nadia, Rasool, Mahmood, Asif, Muhammad, Qazi, Mehmood Husssain, Oraibi, Saleh, Gill, Ammara T, Al Jamaan, Khalid, Iqbal, Mudassar, Khalid, Ahmad Mukhtar
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Loading…
CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML
Absar, Muhammad, Alanazi, Nawaf, Siyal, Abdulaziz, Shammas, Masood, Mahmood, Amer, Basit, Sulman, AlMukhaylid, Sarah, Iqbal, Zafar
Published in Journal of population therapeutics and clinical pharmacology (27.06.2022)
Published in Journal of population therapeutics and clinical pharmacology (27.06.2022)
Get more information
Journal Article
Loading…
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry
Gora-Tybor, Joanna, Sacha, Tomasz, Waclaw, Joanna, Niesiobedzka, Joanna, Grzybowska-Izydorczyk, Olga, Medras, Ewa, Deren-Wagemann, Izabela, Patkowska, Elzbieta, Seferynska, Ilona, Lewandowski, Krzysztof, Wache, Anna, Blajer-Olszewska, Beata, Watek, Marzena, Warzocha, Krzysztof, Jamroziak, Krzysztof
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Loading…
Frequency of a Highly Polymorphic Variant, S36N GFI1, Is Increased in CML Patients
Kaeda, Jaspal S, Amini, Leila, Quintarelli, Concetta, von Wunsch-Rolshoven, Iris, Ringel, Frauke, Schwarz, Michaela, Pane, Fabrizio, Dörken, Bernd, le Coutre, Philipp
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Loading…
Incidence of Type II Diabetes Mellitus and Hyperlipidemia in Patients Prescribed Dasatinib or Nilotinib As First or Second Line Therapy for Chronic Myelogenous Leukemia (CML)
Franklin, Meg, Burns, Leah, Perez, Samuel, Yerragolam, Deepak, Makenbaeva, Dinara
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Loading…
A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions
Webster, Jonathan Allen, Ferguson, Anna, Gocke, Christopher, Jones, Richard J, Levitsky, Hyam, Smith, B. Douglas
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Loading…
Loading…
Loading…
Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients
Alaiya, Ayodele, Chaudhri, Naeem A., Malhan, Hafiz, Owaidah, Tarek, Shinwari, Zakia, Fox, Jonathan, Alsharif, Fahad, Mohamed, Said, Rasheed, Walid, Syed, Osman Ahmed, Aljurf, Mahmoud D.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Loading…
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
Galimberti, Sara, Petrini, Mario, Baratè, Claudia, Ricci, Federica, Balducci, Serena, Grassi, Susanna, Guerrini, Francesca, Ciabatti, Elena, Mechelli, Sandra, Di Paolo, Antonello, Baldini, Chiara, Baglietto, Laura, Macera, Lisa, Spezia, Pietro Giorgio, Maggi, Fabrizio
Published in Frontiers in oncology (02.09.2020)
Published in Frontiers in oncology (02.09.2020)
Get full text
Journal Article
Loading…
Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib
Takahashi, Naoto, Miura, Masatomo, Kuroki, Jun, Mitani, Kinuko, Kitabayashi, Atsushi, Sasaki, Osamu, Kimura, Hideo, Imai, Kiyotoshi, Tsukamoto, Norifumi, Noji, Hideyoshi, Kondo, Takeshi, Kuwayama, Akihisa, Motegi, Mutsuhito, Kato, Yuichi, Takahashi, Kaoru, Mita, Masayuki, Saito, Hajime, Yoshida, Chikashi, Torimoto, Yoshihiro, Kimura, Tomofumi, Wano, Yuji, Nomura, Jun, Yamamoto, Satoshi, Mayama, Ko, Honma, Riko, Sugawara, Tomohiro, Sato, Shinji, Shinagawa, Atsushi, Chubachi, Akihiko, Harigae, Hideo, Sawada, Kenichi
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Loading…
Modeling CML Development and Drug Resistance Using iPSC Technology
Suknuntha, Kran, Ishii, Yuki, Hu, Kejin, Wang, Jean YJ, Slukvin, Igor
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Loading…
Increased MSI2 expression Is Associated with Aggressive CML and AML
Kaeda, Jaspal S, Mills, Ken I., Kharas, Michael G, Saglio, Giuseppe, Schwarz, Michaela, Oberender, Christian, Pawlaczyk-Peter, Bärbel, van Lessen, Antje, Türkmen, Seval, Baldus, Claudia D, Ringel, Frauke, Pretzsch, Thomas, Grille, Peggy, Serra, Anna, Carson, Anne, McMullin, Mary Frances, Westermann, Jörg, Daniel, Peter, Dörken, Bernd, le Coutre, Philipp D.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Loading…
Dietary intake increases serum levels of carboxymethil-lysine (CML) in diabetic patients
Jara, N, Leal, M J, Bunout, D, Hirsch, S, Barrera, G, Leiva, L, de la Maza, M P
Published in Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral (01.07.2012)
Published in Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral (01.07.2012)
Get full text
Journal Article
Loading…
Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody
Schalkwijk, Casper G, Baidoshvili, Alexi, Stehouwer, Coen D.A, van Hinsbergh, Victor W.M, Niessen, Hans W.M
Published in Biochimica et biophysica acta. Molecular and cell biology of lipids (22.03.2004)
Published in Biochimica et biophysica acta. Molecular and cell biology of lipids (22.03.2004)
Get full text
Journal Article
Loading…
CML-623 XS004 Dasatinib (XS004) Improves Variability and Bioavailability in Humans Using Amorphous Solid Dispersion Formulation of Dasatinib With Potential Implications for Its Clinical Use
Lennernäs, Hans, Liljebris, Charlotta, Brisander, Magnus, Jesson, Gerald, Andersson, Per
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Loading…
Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients
Norozi, Fatemeh, Mohammadi-asl, Javad, Vosoughi, Tina, Far, Mohammad Ali Jalali, Malehi, Amal Saki, Saki, Najmaldin
Published in Frontiers in biology (01.10.2016)
Published in Frontiers in biology (01.10.2016)
Get full text
Journal Article
Loading…
High Frequencies Of Switching To 2nd TKIs and Failure To Maintain Standard Imatinib Dose In Japanese CML Patients With BIM Genetic Variants
Katagiri, Seiichiro, Tauchi, Tetsuzo, Umezu, Tomohiro, Ohtsuki, Kazuhiro, Tadokoro, Kenichi, Yamamoto, Yoshinori, Ohyashiki, Junko H, Ohyashiki, Kazuma
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Loading…